KALA BIO (KALA) Short Interest Ratio & Short Volume → What’s Really Next for America… (From Porter & Company) (Ad) Free KALA Stock Alerts $6.68 -0.05 (-0.74%) (As of 09:53 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability KALA BIO Short Interest DataCurrent Short Volume8,800 sharesPrevious Short Volume5,100 sharesChange Vs. Previous Month+72.55%Dollar Volume Sold Short$60,720.00Short Interest Ratio / Days to Cover0.5Last Record DateApril 30, 2024Outstanding Shares2,820,000 sharesFloat Size2,420,000 sharesShort Percent of Float0.36%Today's Trading Volume325 sharesAverage Trading Volume22,338 sharesToday's Volume Vs. Average1% Short Selling KALA BIO ? Sign up to receive the latest short interest report for KALA BIO and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatKALA Short Interest Over TimeKALA Days to Cover Over TimeKALA Percentage of Float Shorted Over Time Ad Crypto 101 Media“Dollar Will Be Worth NOTHING” -MuskElon Musk just issued an urgent warning… Saying “The U.S. Dollar will be worth NOTHING…” As "stealth money printing" pushes the price of Bitcoin, Ethereum, XRP and crypto higher.Click here to claim your free seat ticket now. KALA BIO Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20248,800 shares $60,720.00 +72.6%0.4%0.5 $6.90 4/15/20245,100 shares $35,700.00 -15.0%0.2%0.2 $7.00 3/31/20246,000 shares $47,820.00 -50.4%0.3%0.2 $7.97 3/15/202412,100 shares $91,113.00 +22.2%0.5%0.4 $7.53 2/29/20249,900 shares $71,082.00 -18.2%0.4%0.2 $7.18 2/15/202412,100 shares $86,999.00 -28.4%0.5%0.1 $7.19 Get the Latest News and Ratings for KALA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for KALA BIO and its competitors with MarketBeat's FREE daily newsletter. 1/31/202416,900 shares $117,455.00 -50.2%0.8%0.2 $6.95 1/15/202433,900 shares $272,895.00 +20.2%1.6%0.4 $8.05 12/31/202328,200 shares $197,400.00 -61.6%1.4%0.4 $7.00 12/15/202373,500 shares $498,330.00 +34.9%3.4%1.1 $6.78 11/30/202354,500 shares $329,725.00 -14.0%2.6%0.8 $6.05 11/15/202363,400 shares $334,752.00 +0.2%3.0%3.6 $5.28 10/31/202363,300 shares $430,440.00 -15.8%3.2%3.3 $6.80 10/15/202375,200 shares $614,376.48 -24.8%3.8%3 $8.17 9/30/2023100,000 shares $890,000.00 +48.4%4.9%3.2 $8.90 9/15/202367,400 shares $716,462.00 +632.6%3.3%1.7 $10.63 8/31/20239,200 shares $123,464.00 -87.8%0.5%0.2 $13.42 8/15/202375,500 shares $1.03 million -18.6%3.8%1.2 $13.70 7/31/202392,800 shares $1.39 million -51.0%4.6%1.2 $15.03 7/15/2023189,400 shares $2.73 million -0.7%10.2%2.2 $14.43 6/30/2023190,800 shares $2.78 million +34.0%10.3%1.6 $14.59 6/15/2023142,400 shares $2.10 million -4.9%7.8%1 $14.73 5/31/2023149,800 shares $2.14 million -20.1%7.5%0.7 $14.30 5/15/2023187,500 shares $3.13 million +12.6%9.4%0.3 $16.67 4/30/2023166,500 shares $2.63 million -3.1%10.0%0.3 $15.77 4/15/2023171,900 shares $2.86 million -32.9%10.4%0.2 $16.63 3/31/2023256,200 shares $3.86 million +29.5%15.4%0.3 $15.05 3/15/2023197,800 shares $3.30 million -20.6%12.4%0.1 $16.69 2/28/2023249,100 shares $2.52 million +16.6%18.5%0.1 $10.13 2/15/2023213,600 shares $2.73 million -29.6%15.4%0.1 $12.78 1/31/2023303,200 shares $5.26 million +28.3%22.6%0.1 $17.34 1/15/2023236,300 shares $4.64 million -52.2%17.6%0.1 $19.62 12/30/2022494,700 shares $18.87 million +389.3%38.4%0.2 $38.15 12/15/2022101,100 shares $442,818.00 +5.4%7.8%0.5 $4.38 11/30/202295,900 shares $507,311.00 +25.2%7.5%0.5 $5.29 11/15/202276,600 shares $491,772.00 +74.5%6.0%0.5 $6.42 10/31/202243,900 shares $278,765.00 +32.6%3.9%0.3 $6.35 10/15/202233,100 shares $415,405.00 -97.9%N/A1.2 $12.55 9/30/20221,610,000 shares $356,454.00 -13.0%2.7%1.6 $0.22 9/15/20221,850,000 shares $626,780.00 -11.9%3.1%1.4 $0.34What’s Really Next for America… (Ad)Millions of Unsuspecting Americans Could be Wiped Out… Yet those who watch this bombshell exposé and prepare before it’s too late could have the chance to protect their financial future and grow their wealth significantly.Click here to stream this controversial exposé now. KALA Short Interest - Frequently Asked Questions What is KALA BIO's current short interest? Short interest is the volume of KALA BIO shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 8,800 shares of KALA short. 0.36% of KALA BIO's shares are currently sold short. Learn More on KALA BIO's current short interest. What is a good short interest percentage for KALA BIO? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.36% of KALA BIO's floating shares are currently sold short. Is KALA BIO's short interest increasing or decreasing? KALA BIO saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 8,800 shares, an increase of 72.5% from the previous total of 5,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is KALA BIO's float size? KALA BIO currently has issued a total of 2,820,000 shares. Some of KALA BIO's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. KALA BIO currently has a public float of 2,420,000 shares. How does KALA BIO's short interest compare to its competitors? 0.36% of KALA BIO's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to KALA BIO: NeuroBo Pharmaceuticals, Inc. (2.06%), BioVie Inc. (3.18%), Cocrystal Pharma, Inc. (0.11%), Synlogic, Inc. (0.36%), Alaunos Therapeutics, Inc. (9.57%), Indaptus Therapeutics, Inc. (0.44%), Lumos Pharma, Inc. (6.09%), Sol-Gel Technologies Ltd. (0.04%), Orgenesis Inc. (0.84%), Aytu BioPharma, Inc. (7.15%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short KALA BIO stock? Short selling KALA is an investing strategy that aims to generate trading profit from KALA BIO as its price is falling. KALA shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against KALA BIO? A short squeeze for KALA BIO occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of KALA, which in turn drives the price of the stock up even further. How often is KALA BIO's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KALA, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: NeuroBo Pharmaceuticals Short Squeeze BioVie Short Squeeze Cocrystal Pharma Short Squeeze Synlogic Short Squeeze Alaunos Therapeutics Short Squeeze Indaptus Therapeutics Short Squeeze Lumos Pharma Short Squeeze Sol-Gel Technologies Short Squeeze Orgenesis Short Squeeze Aytu BioPharma Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KALA) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceWhy Is Gold On a MASSIVE rally? Huge AlertsHow Biden has already won 2024Porter & Company348 million Americans lives to END as we know it?The Oxford ClubMissed NVDA? Buy this AI stock NOWChaikin AnalyticsDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldBiden Nomination CANCELED?The Freeport Society